A5036096146- Schizophrenia research and treatment
- Pharmaceutical studies and practices
- Attention Deficit Hyperactivity Disorder
- Bipolar Disorder and Treatment
- Cardiac electrophysiology and arrhythmias
- Diet and metabolism studies
- Child and Adolescent Psychosocial and Emotional Development
- Vascular Procedures and Complications
- Family Caregiving in Mental Illness
- Asthma and respiratory diseases
- Pituitary Gland Disorders and Treatments
- Adolescent and Pediatric Healthcare
- Pharmacy and Medical Practices
- Diabetes Treatment and Management
- Acute Myocardial Infarction Research
- Neurological and metabolic disorders
- Pharmacological Effects and Toxicity Studies
- Eosinophilic Disorders and Syndromes
- Peripheral Artery Disease Management
- Pharmacology and Obesity Treatment
- Growth Hormone and Insulin-like Growth Factors
- Parasitic Infections and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Pancreatic function and diabetes
- Coordination Chemistry and Organometallics
Oita University
2024-2025
Tsurumi University
2024
Tsuchiura Kyodo General Hospital
2010
Otsuka Pharmaceutical (Spain)
2008
Transradial coronary intervention (TRI) introduces a trauma to the radial artery (RA), possibly influencing quality as bypass conduit if subsequently used. We sought determine acute and chronic effects of TRI on RA by optical coherence tomography (OCT).Immediately after completion, 73 RAs in 69 patients were examined. The sheath was pulled back 2 cm distal puncture site, OCT imaging performed. injuries intimal thickening compared between first-TRI repeat-TRI RAs. Intimal tears observed 49...
Background:There is limited published data from long-term pediatric bipolar clinical trials with which to guide appropriate treatment decisions. Long-term efficacy and safety of aripiprazole was investigated in this patient population.Methods:296 youths, ages 10-17 year-old a DSM-IV diagnosis I disorder were randomized receive either placebo or (10mg 30mg) 4-week double-blind trial. Completers continued assigned treatments for an additional 26 weeks (double-blind). Efficacy endpoints...